Harrow Health (HROW) Tops Q2 EPS by 2c

Harrow Health (NASDAQ: HROW) reported Q2 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $33.5 million versus the consensus estimate of $30.34 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Broadcom credit risk measures rise amid AI financing deals
• Bernstein SocGen Group Upgrades Square Enix Holdings (9684:JP) (SQNNY) to Outperform
• NAPCO Security Tech (NSSC) Tops Q4 EPS by 11c